Compare Inovio Pharmaceuticals Inc (INO) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Snap Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Snap Inc trades at $5.49 (market cap $9.32B). The key difference: Snap Inc is far larger — about 118.7× Inovio Pharmaceuticals Inc's market cap, and Snap Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | SNAP | |
|---|---|---|
Market Cap | $78.55M | $9.32B |
Sector | Health | Media |
52-Week High | $2.87 | $9.09 |
52-Week Low | $0.66 | $3.93 |
Enterprise Value | $49.56M | $10.88B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
